If you or your loved one has developed Fournier’s Gangrene after taking Farxiga for diabetes, the Farxiga lawyers at Williams Kherkher are ready to fight for you. Our nationally-recognized pharmaceutical attorneys have a notable track record of success with handling these types of claims, and we will not rest until you get the full and fair compensation that the drug’s manufacturers owe you.
Billions Recovered for Our Clients
Contact us today at (866) 303-0395 to start your FREE consultation.
Farxiga is a sodium-glucose cotransporter-2 (SGLT2) inhibitor, which is a class of type 2 diabetes medicines. The drug has been shown to cause serious necrotizing fasciitis of the perineum, more commonly known as Fournier’s gangrene, and people who have contracted this incredibly painful and horrific condition may be entitled to significant compensation.
For more than three decades, the aggressive trial attorneys have challenged powerful corporations and other entities that have caused harm to individuals and their families across the United States. Whenever people are hurt by a defective drug, we will be there to stand up for their rights and seek justice and accountability from the big pharmaceutical companies.
Time is limited to file a claim against the company that manufactured the diabetes drug that harmed you, so don’t wait to contact us for a FREE, confidential consultation. We will listen to you and will discuss your rights and options. Call us at (866) 303-0395, or contact us online to get started right away.
Did you take Farxiga? Did you develop Fournier’s gangrene? You could be owed compensation.
Companies must conduct numerous tests on drugs before bringing them to market. Warning labels must indicate all possible known side effects, add the manufacturer is responsible for updating these labels even after the United States Food and Drug Administration (FDA) has approved the drug.
Bristol-Myers Squibb Co. and AstraZeneca have a history of paying high-figure settlements and jury awards to people who have been harmed by the drugs they manufacture, market, and sell, including:
$65 Million – AstraZeneca – 2012 – European Commission
- The European Court of Justice rejected AstraZeneca’s appeal after it was fined €52.5 million ($68 million) for trying to prevent the marketing of generic versions of omeprazole, which was marketed in the United Kingdom as Losec.
$20 Million – AstraZeneca – 2015 – Deceptive Advertising
- AstraZeneca ran an advertising campaign that exaggerated the differences between two of its PPIs, Nexium and Prilosec. AstraZeneca ultimately paid $20 million to settle a lawsuit related to that campaign.
$7.9 Million – AstraZeneca – 2015 – Kickbacks to Pharmacy Benefit Managers
- AstraZeneca had to pay $7.9 million to settle a lawsuit stemming from kickback payments AstraZeneca made to Medco Health Solutions to make its PPI the only one covered by the pharmacy benefits management company.
You should know that it will not cost you one cent to discuss your case with Williams Kherkher. Our firm represents clients on a contingency fee basis, meaning you won’t have to pay us anything unless we win your case.
What are SGLT2 inhibitors? What is Fournier’s gangrene?
The FDA states that SGLT2 inhibitors are approved by the agency for use with diet and exercise to lower blood sugar in adults with type 2 diabetes. SGLT2 inhibitors cause the kidneys to remove sugar from the body through the urine, leading to lower blood sugar.
Dapagliflozin, or Farxiga, was one of the SGLT2 inhibitors mentioned explicitly in an FDA press release in August of 2018 warning about cases of Fournier’s gangrene developing in patients who were on SGLT2 inhibitor therapy. The FDA described Fournier’s gangrene as an “extremely rare but life-threatening bacterial infection.”
Patients who develop Fournier’s gangrene report symptoms including:
- Pain, swelling, and tenderness in the genitals and genital area
- A crackling sound when the affected area is touched
- A foul odor coming from the affected area
If you suspect that you have developed this infection, seek immediate medical treatment. Fournier’s gangrene is usually treated through broad-spectrum antibiotics administered by IV, as well as surgery to remove the dead and dying tissue.
Contact the Farxiga attorneys of Williams Kherkher today
Did you or your loved one recently develop Fournier’s gangrene after using Farxiga? You could be entitled to compensation, and Williams Kherkher is ready to fight for you. We are committed to helping people who took Farxiga and other diabetes drugs, believing they would help them control the condition, and who developed a dangerous infection as a result. We believe that justice should be served for everyone who was forced to deal with Fournier’s gangrene as a result of taking Farxiga, and we won’t rest until you get the full and fair compensation you are owed.
Williams Kherkher has made a name for itself fighting for people across the U.S. who were injured by dangerous drugs. Call (866) 303-0395 or contact us to schedule a FREE, no-obligation consultation with a compassionate member of our team today.